Search

everythinglearnresearchcommunity

for

Search:↓

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Ultrasound can improve targeted drug delivery, making treatments more effective with fewer side effects.

Finasteride tablets and capsules work the same in the body.

Computational methods can speed up and improve the development and safety of herbal drugs.

In 2011, there were major scientific breakthroughs in cancer treatment, immunity, Parkinson's, virus simulation, schizophrenia, hair growth, lung cancer, and medical grafts.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

The new delivery system improves treatment for hair loss by enhancing drug absorption and effectiveness.

The nanoparticles improved minoxidil's skin absorption, making them promising for skin treatments.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

SUN11602 and ONO-1301 could help in skin healing and creating artificial skin.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Transforming skin disease treatment requires new strategies, better drug models, and patient-focused research.

Unapproved stem cell therapies are marketed online in the UK, raising safety and regulation concerns.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

Five FDA-approved drugs may help block COVID-19 virus entry.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

Liposomes could improve how skin care products work but are costly and not very stable.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Finding new uses for existing drugs is promising and can lead to safer, more effective medicines.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

Combining tadalafil and finasteride improves their solubility and effectiveness.

The technology can help diagnose and subtype autoimmune diseases by identifying specific autoantibodies.